Diuretic Selection in Elderly CKD Patients

Introduction to Diuretic Therapy

The American College of Cardiology recommends torsemide as the preferred loop diuretic over furosemide in elderly patients with CKD due to its longer duration of action and superior efficacy in this population 1

Torsemide provides a 12-16 hour duration of action compared to furosemide's 6-8 hours, reducing the burden of multiple daily doses in elderly patients 2, 1
The maximum daily dose of torsemide is 200 mg versus furosemide's 600 mg, suggesting greater potency per milligram 2, 1
Once-daily dosing of torsemide improves medication adherence, a critical factor in elderly populations with CKD 1

Chlorthalidone can be considered in elderly CKD patients with resistant hypertension, even with advanced CKD, contrary to traditional teaching 5
The European Society of Cardiology guidelines note that thiazides should not be automatically discontinued when eGFR decreases below 30 mL/min/1.73 m² 6, 7
Chlorthalidone demonstrated a BP reduction of 10.5 mm Hg in patients with mean eGFR of 26.8 mL/min/1.73 m² after 12 weeks 5
The duration of action of chlorthalidone is 24-72 hours, providing a sustained effect with once-daily dosing 2

The European Society of Cardiology recommends adding chlorthalidone to torsemide for synergistic effect by blocking distal sodium reabsorption 1
Consider spironolactone to counter hypokalemia and improve resistant hypertension 6, 7, 1

Check electrolytes and eGFR within 2-4 weeks of initiation or dose escalation of chlorthalidone 5
Monitor closely for hyponatremia, which carries heightened risk in the elderly 6, 7, 5
Avoid using thiazides in patients with a history of gout, diabetes, or hyperlipidemia where possible 6, 7
Failing to increase loop diuretic doses in advanced CKD can lead to reduced efficacy 2, 1
Automatically discontinuing thiazides at GFR <30 mL/min without assessing individual risk-benefit can lead to inadequate treatment 6, 7, 5